4.49

5.07% -0.24

After Hours: 4.70 0.21 +4.68%

Turn Therapeutics Inc (TTRX)

Overview News Price History Discussions Forecast

Turn Therapeutics Inc stock is traded at $4.49, with a volume of 42,468. It is down -5.07% in the last 24 hours and up +4.18% over the past month. Turn Therapeutics Inc is a clinical-stage biotechnology company focused on developing pharmaceutical and medical device products for dermatology, wound care, and infectious disease. The company's proprietary platform technology, called PermaFusion, enhances drug performance by improving the stability and bioavailability of active pharmaceutical ingredients, which allows for reduced doses and fewer side effects. Its primary development programs target skin conditions such as moderate to severe eczema and onychomycosis.

Previous Close:

$4.73

Open:

$4.8

24h Volume:

42,468

Relative Volume:

0.10

Market Cap:

$132.21M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+21.02%

1M Performance:

+4.18%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$4.48

$4.99

1-Week Range:

$3.678

$5.22

52-Week Range:

$2.5701

$26.50

Turn Therapeutics Inc Stock (TTRX) Company Profile

Name

Turn Therapeutics Inc

Sector

Healthcare (1114)

Industry

Biotechnology (625)

Phone

(818) 564-4011

Address

250 NORTH WESTLAKE BLVD., WESTLAKE VILLAGE

Employee

Twitter

Next Earnings Date

Latest SEC Filings

TTRX's Discussions on Twitter

Compare TTRX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TTRX Turn Therapeutics Inc	4.49	139.28M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	468.38	113.87B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	776.54	80.22B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	406.40	52.56B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	803.74	49.31B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	175.07	37.37B	447.02M	-1.18B	-906.14M	-6.1812

Turn Therapeutics Inc Stock (TTRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-29-25	Initiated	D. Boral Capital	Buy

Turn Therapeutics Inc Stock (TTRX) Latest News

Jan 01, 2026

Ceapro (OTCMKTS:CRPOF) vs. Turn Therapeutics (NASDAQ:TTRX) Head to Head Review - Defense World

Jan 01, 2026

Turn Therapeutics (NASDAQ:TTRX) Upgraded at D Boral Capital - Defense World

Jan 01, 2026

Dec 30, 2025

Turn Therapeutics (NASDAQ:TTRX) Now Covered by Analysts at D. Boral Capital - Defense World

Dec 30, 2025

Dec 29, 2025

TTRX Analyst Forecasts - Quiver Quantitative

Dec 29, 2025

Turn Therapeutics Inc. Common Stock (TTRX) Stock News & Articles - 24/7 Wall St.

Dec 29, 2025

D. Boral Capital initiates Turn Therapeutics stock with Buy rating By Investing.com - Investing.com Canada

Dec 29, 2025

Dec 27, 2025

What date does Turn Therapeutics Inc.'s (TTRX) report EarningsEarnings Calendar & Announcement - Zacks Investment Research

Dec 27, 2025

Dec 24, 2025

Death Cross: Is Beam Therapeutics Inc. stock a defensive play in 2025Exit Point & Safe Entry Zone Identification - moha.gov.vn

Dec 24, 2025

Dec 23, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Dec 23, 2025

Dec 22, 2025

Will Tempest Therapeutics Inc. stock beat EPS estimatesJuly 2025 Weekly Recap & Weekly High Potential Stock Alerts - bolumsonucanavari.com

Dec 22, 2025

Dec 21, 2025

Portfolio Shifts: Is Enliven Therapeutics Inc. stock near bottom after decline2025 Volatility Report & Daily Entry Point Trade Alerts - moha.gov.vn

Dec 21, 2025

Will Whitehawk Therapeutics Inc. stock recover faster than market2025 Earnings Surprises & Detailed Earnings Play Alerts - Улправда

Dec 21, 2025

Dec 20, 2025

Can Karyopharm Therapeutics Inc. stock resist sector downturnsJuly 2025 Market Mood & High Accuracy Trade Alerts - Улправда

Dec 20, 2025

Why MiNK Therapeutics Inc. stock attracts global investors2025 Market Trends & Short-Term High Return Ideas - Улправда

Dec 20, 2025

Is Foghorn Therapeutics Inc. stock resilient to inflation2025 Support & Resistance & Real-Time Chart Breakout Alerts - Улправда

Dec 20, 2025

Why Anika Therapeutics Inc. stock remains on watchlistsMarket Activity Report & Community Trade Idea Sharing - Улправда

Dec 20, 2025

Dec 19, 2025

Will Neumora Therapeutics Inc. stock benefit from AI adoptionOil Prices & Weekly Setup with High ROI Potential - Улправда

Dec 19, 2025

Loss Report: Can Xilio Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 EndofMonth & High Win Rate Trade Alerts - Улправда

Dec 19, 2025

Will Intensity Therapeutics Inc. stock split attract more investorsJuly 2025 News Drivers & AI Based Buy and Sell Signals - Улправда

Dec 19, 2025

How geopolitical tensions affect Spyre Therapeutics Inc. stock2025 Historical Comparison & Real-Time Volume Trigger Notifications - ulpravda.ru

Dec 19, 2025

Is Cidara Therapeutics Inc. stock a top momentum playMarket Activity Report & AI Enhanced Trade Execution Alerts - Улправда

Dec 19, 2025

Is Beam Therapeutics Inc. stock cheap compared to fundamentalsMarket Growth Report & Short-Term High Return Strategies - Улправда

Dec 19, 2025

Dec 18, 2025

Is Aquestive Therapeutics Inc. stock positioned for digital transformation2025 Key Highlights & Expert Approved Trade Ideas - Улправда

Dec 18, 2025

Will Tempest Therapeutics Inc. stock split again soonJuly 2025 Earnings & Accurate Intraday Trading Signals - Улправда

Dec 18, 2025

How Marker Therapeutics Inc. (GX1) stock reacts to new regulationsJuly 2025 Earnings & Low Volatility Stock Recommendations - Улправда

Dec 18, 2025

Will TG Therapeutics Inc. stock benefit from automationMarket Activity Report & Free Expert Verified Stock Movement Alerts - Улправда

Dec 18, 2025

Dec 15, 2025